AzTrials
AzTrials

Cerebrovascular DisordersNCT03491111

The Outcome of Respiratory Muscle Training in Stroke Patients

A study testing Respiratory muscle training for EMT+IMT, Regular Rehabilitation and Respiratory muscle training for EMT in people with Cerebrovascular Disorders, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Stroke survivors commonly have respiratory muscle weakness, swallowing disturbance, general weakness, reduced the daily living activities and short of motivation for rehabilitation. Read more about this study

Who is it for?
Ages 35 to 80 years
Conditions the study is for
Cerebrovascular Disorders
What is being tested?
Respiratory muscle training for EMT+IMT, Regular Rehabilitation and Respiratory muscle training for EMT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteTaiwan
Study dates
1 Apr 2016to 31 Jul 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients identified as stroke and capable of performing voluntary respiratory maneuvers.

Who cannot join

  • Increased intracranial pressure
  • Uncontrolled hypertension
  • Complicated arrhythmia
  • Decompensated heart failure
  • Unstable angina
  • Myocardial infarction in the preceding 3 months
  • Pneumothorax, bullae/blebs or infection.

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Department of Physical Medicine and Rehabilitation, Kaohsiung Chang Gung Memorial Hospital.

    Kaohsiung City, 83305

Other trials in Taiwan

About this study

Official title: The Outcome of Respiratory Muscle Training in Stroke Patients: A Prospective Study

Stroke survivors commonly have respiratory muscle weakness, swallowing disturbance, general weakness, reduced the daily living activities and short of motivation for rehabilitation. Respiratory muscle training (RMT) has been reported to improve the pulmonary function, respiratory muscle strength, exercise capacity, sensation of dyspnea and quality of life in several diseases, but rare in stroke patients. Reviewing previous reports, the protocol, intensity and duration of respiratory muscle training is still variable.

Purpose: To investigate the feasibility and efficacy of respiratory muscle training on cardio-pulmonary function, swallowing function, cough function and reduction of incidence of pneumonia in post-stroke patients.

Read more

Methods: A prospective, single blinded, randomized study. Consecutive patients with diagnosis of stroke will be proved by magnetic resonance image or computerized tomography. Stroke patients, aged 35-80 years old, with inspiratory muscle weakness or swallowing disturbance will be enrolled and randomly divided into control group (usual rehabilitation alone) and experimental group [inspiratory muscle training (IMT) group for patients with inspiratory muscle weakness and expiratory muscle strengthening training (EMT) for patients with swallowing disturbance]. Each patients will receive usual rehabilitation.

The investigator expect that RMT will be practical for the restoration of respiratory muscle, swallowing function, cough function and voice quality, thereby reduction of the incidence of pneumonia.

Read the detailed description

Stroke patients has been observed to have a higher position of diaphragm in thoracic radiographs on the affected side after 1 day to 2 years of acute event, reduced movement of whole hemi-thorax and excursion of diaphragm on the affected side during deep voluntary breathing, and a tendency for predominance of rib cage contributions during tidal breathing, reduced maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP). Their cardiorespiratory fitness could be markedly impaired within 7 weeks after a stroke. Neves, et al. reported that the recent infarction group had a positive correlation between peak oxygen uptake and both MIP and maximal incremental pressure.

Inspiratory muscle training (IMT). Inspiratory loading can improve limb blood flow, and oxygen uptake efficiency. Threshold inspiratory loading has been recommended to improve inspiratory muscle strength in chronic obstructive pulmonary disease (COPD), bronchiectasis, congestive heart failure (CHF), heart failure, CABG and neuromuscular disease et al. Sutbeyaz et al. ever reported that a statistically significant increase in MIP and MEP of the breathing retraining group in subacute stroke patients. The training intensity of IMT varied from 30% to 60% of MIP, duration of 3 to 7 times per week, the duration of each session from 10-30 minutes for a period of training from 6 to12 weeks.

Expiratory muscle training (EMT): EMT has been shown to improve the dyspnea perception and walking distance within a time unit in COPD persons, aerodynamic changes in cough flow in patients with multiple sclerosis and Parkinson disease, and swallowing safety in PD, and voice aerodynamic. But till now, the protocol, intensity and duration of EMT is still variable, from twice daily at the user's own frequency and tidal volume for 15 min for 4 week, or a week for 1/2 hour, start 15% MEP max, increased by 5-10% each session to 60% of MEP.

Method: Forty-six stroke patients with swallowing disturbance or respiratory muscle weakness, age between 35 to 80 years, will be enrolled. The participants will be randomly assigned by a computer random number generator into two groups, including the experimental group (RMT group plus regular rehabilitation) and the control group (regular rehabilitation alone). All allocations will be concealed in the opaque envelopes. The research assistant will enroll the participants, generate the allocation sequence, and assign participants to their groups after obtaining the informed consent. The research assistant who are responsible for measuring outcomes will be blind to the allocation.

Experimental group will be randomized into 2 groups:

Group I: EMT+IMT for patients with inspiratory muscle weakness and swallowing disturbance (MIP less than 70% of normal range).

Group II: EMT for patients with swallowing disturbance.

Control group will receive regular rehabilitation.

Each subject with respiratory muscle weakness or swallowing disturbance, baseline characteristics, including height, weight, body mass index, duration of the disease, neurological level (Brunnstrom's stage), spirometry, peak cough flow, resting heart rate, systolic and diastolic blood pressure, resting oxyhemoglobin saturation (SpO2), MIP, MEP , Borg's scale (0.5 to 10), 6-minute walking test, cough function, fatigue assessment scale.

Training protocol Group I: IMT+EMT:

IMT will commence from 30% to 60 % of MIP and then adjust one level of training loading according to the tolerance of continuously breathing through a respiratory trainer for one set of 30 breaths or 6 sets of 5 repetitions with one or two minute of rest between sets, twice per day, 5 days per week. Training resistance will be adjusted as tolerated. The loading will be performed with the previous resistance setting or even lower if training load is not tolerated or not completed.

During IMT, patients will be instructed to place their lips around breathing trainer in a sitting position with a nose-clip, inhale with enough force to open the valve (inhale deeply and forcefully), exhale through the mouthpiece (exhale slowly and gently), and then continue inhaling and exhaling without removing the device from their mouths. The training load and training program will be instructed by an experienced respiratory technician.

Training protocol Group II: EMT for patients with swallowing disturbance EMT will commence from 15% to 75% of threshold load of an individual's MEP, 5 sets, 5 repetition with one or two minute of rest between sets, twice per day, 5 days per week. And training resistance will be adjusted accordingly. The loading will be performed with the previous resistance setting or even lower if training load is not tolerated or not completed.

Each patients with swallowing disturbance will receive swallowing screen test, Functional Oral Intake Scale, voice quality analysis and surface electromyography by an experience physician and experienced speech therapist to evaluate the functional level of oral intake of food and liquid, voice quality and measurement of submental muscle strength respectively. And swallowing training program will be conducted by an experienced speech therapist.

Procedures for surface EMG (sEMG): The sEMG activities of swallowing-related muscles while swallowing and doing expiratory breathing through a breathing trainer will be measured with the Nicolet Viking Four Electrodiagnostic system, Multiple Modality Program.

Procedures for voice analysis: Voice quality will be assessed with Computerized Speech Lab (CSL™),Model 4500 (Mutlti-Dimensional Voice). Patients will sustain "ah" for at least 3 seconds at the most comfortable speaking pitch and loudness, as well as at the lowest pitch and highest pitch increasing and decreasing loudness with audio recording.

Each patient will be assessed again at 6 weeks later.

Supervision: During the first session, the investigator will decrease one level of threshold load imposed if a modest decrease in SpO2, which implies that it most likely reflects the onset of hypoventilation, particularly when the load approaches the maximum; otherwise the investigators will use continuous use EKG to monitor cardiac activity throughout the RMT session.

Regular rehabilitation program All participants will receive usual rehabilitation care including body positioning instruction, postural correction, breathing control, cough maneuver, respiratory muscle stretch, chest wall mobility exercise, fatigue management.

For checking the compliance of RMT at home, patients will be monitored by making a phone call to them once a week.

Being tested
Respiratory muscle training for EMT+IMT, Regular Rehabilitation, Respiratory muscle training for EMT
Keywords
Cerebrovascular disease, respiratory muscle training, spirometry, peak flow, maximal inspiratory pressure, maximal expiratory pressure
Medical subject headings
Cerebrovascular Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Respiratory muscle training for EMT+IMTOther

    2 times per day and 5 day per week, 6 weeks, training with breathing trainer.

  • Regular RehabilitationOther

    Regular Rehabilitation: 2-3 times a week, 6 weeks.

  • Respiratory muscle training for EMTOther

    5 sets, 5 repetition with one or two minute of rest between sets, twice per day, 5 days per week, training with breathing trainer.

Study groups in NCT03491111
Study groupRoleWhat they receive
IMT & EMTExperimentalInterventions: Respiratory muscle training for EMT+IMT. Respiratory muscle training for IMT (Inspiratory muscle training)+EMT (Expiratory muscle training). Respiratory muscle breathing training for patients with inspiratory muscle weakness and swallowing disturbance (MIP less than 70% of normal range).
Receives: Other: Respiratory muscle training for EMT+IMT; Other: Regular Rehabilitation
Control groupActive comparatorIntervention: Non-training group, receive regular rehabilitation. All participants will receive usual rehabilitation care including body positioning instruction, postural correction, breathing control, cough maneuver, respiratory muscle stretch, chest wall mobility exercise and ventilation, fatigue management.
Receives: Other: Regular Rehabilitation
EMT groupExperimentalIntervention: Respiratory muscle training for EMT. Respiratory muscle breathing training for swallowing disturbance. EMT for patients with swallowing disturbance will commence from 15% to 75% of threshold load of an individual's MEP.
Receives: Other: Regular Rehabilitation; Other: Respiratory muscle training for EMT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. MIP (maximal inspiratory pressure)

    MIP(cm H20) is measured after maximal expiration while patients sitting and wearing a nose-clip. For MIP, more negative pressure is better.

    Measured: At the beginning and the end of program respectively, up to 6 weeks.

  2. MEP (maximal expiratory pressure)

    MEP(cm H20) is measured after maximal inspiration while patients sitting and wearing a nose-clip. For MEP, more positive is better.

    Measured: At the beginning and the end of program respectively, up to 6 weeks.

Secondary outcomes (10)
  1. Forced vital capacity, FVC(liter)

    Pulmonary functional test, the determination of the vital capacity from a maximally forced expiratory effort.

    Measured: At the beginning and the end of program respectively, up to 6 weeks.

  2. Forced vital capacity, FVC(%pred)(liter)

    Pulmonary functional test, the determination of the vital capacity from a maximally forced expiratory effort.

    Measured: At the beginning and the end of program respectively, up to 6 weeks.

  3. Forced expiratory volume 1/Forced vital capacity, FEV1/FVC(%)

    Pulmonary functional test, a calculated ratio used in the diagnosis of obstructive and restrictive lung disease.

    Measured: At the beginning and the end of program respectively, up to 6 weeks.

  4. Maximal mid-expiratory flow, MMEF(%)

    Pulmonary functional test, the peak of expiratory flow as taken from the flow-volume curve and measured in liters per second.

    Measured: At the beginning and the end of program respectively, up to 6 weeks.

  5. Peak cough flow(liter/min)

    Maximum speed of expiration

    Measured: At the beginning and the end of program respectively, up to 6 weeks.

  6. Resting heart rate

    Heart rate of patient during resting.

    Measured: At the beginning and the end of program respectively, up to 6 weeks.

  7. Resting respiratory rate

    Respiratory rate of patient during resting.

    Measured: At the beginning and the end of program respectively, up to 6 weeks.

  8. Functional Oral Intake Scale

    Level 1: Nothing by mouth. Level 2: Tube dependent with minimal attempts of food or liquid. Level 3: Tube dependent with consistent oral intake of food or liquid. Level 4: Total oral diet of a single consistency. Level 5: Total oral diet with multiple consistencies, but requiring special preparation or compensations.Level 6: Total oral diet with multiple consistencies without special preparation, but with specific food limitations. Level 7: Total oral diet with no restrictions. Level 1 to level 7.

    Measured: At the beginning and the end of program respectively, up to 6 weeks.

  9. Borg's Scale

    Modified Borg scale (0.5 to 10)

    Measured: At the beginning and the end of program respectively, up to 6 weeks.

  10. Fatigue Assessment Scale

    Score: 5-50. 1 = Never, 2 = Sometimes; 3 = Regularly; 4 = Often and 5 = Always. 10 items.

    Measured: At the beginning and the end of program respectively, up to 6 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Apr 2018
  2. Study start1 Apr 2016
  3. Primary completion18 Jul 2018
  4. Study completion31 Jul 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03491111
Sponsor's protocol ID
CMRPG8E0911
Status last verified
Nov 2020
First submitted
30 Jan 2018
Last updated
1 Dec 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Liaw MY, Hsu CH, Leong CP, Liao CY, Wang LY, Lu CH, Lin MC. Respiratory muscle training in stroke patients with respiratory muscle weakness, dysphagia, and dysarthria - a prospective randomized trial. Medicine (Baltimore). 2020 Mar;99(10):e19337. doi: 10.1097/MD.0000000000019337.

    PubMed 32150072

Questions about this trial

What is this clinical trial studying?

A study testing Respiratory muscle training for EMT+IMT, Regular Rehabilitation and Respiratory muscle training for EMT in people with Cerebrovascular Disorders, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

MIP (maximal inspiratory pressure) (time frame: At the beginning and the end of program respectively, up to 6 weeks.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03491111, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in